News & Trends - Pharmaceuticals
TGA cautions against over-buying medicines
Pharma News: In response to COVID-19, the TGA is aware that some pharmacists have been over-ordering medicines, while many consumers have been over-buying. This has resulted in some temporary local level out-of-stock situations, which we expect will resolve in the coming week or two.
It is important to understand that a local out-of-stock is not a national medicine shortage.
The large spike in orders from some pharmacies has resulted in other pharmacies not getting the stock they need. This means that consumers may be unable to get the medicines they need.
Stockpiling medicines may disrupt access to vital medicines by patients and pharmacies.
We call on consumers not to purchase more medicines than they need, and we urge health professionals to reassure patients that there is no need to buy more than is necessary. Health professionals should also avoid prescribing or dispensing multiple months of supply of prescription medicines to patients where there is no clinical need to do so.
Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.
We call on pharmacists to avoid over ordering medicines, to help ensure that medicines are available to all Australians who need them.
The Department of Health is closely monitoring medicines supply, and working with sponsors, wholesalers and health professional groups to identify and address issues relating to supply.
Australian law requires medicines companies to report current and anticipated shortages of prescription medicines and certain over-the-counter medicines.
We publish shortage notifications for the information of health professionals and consumers, which you can find on the Medicine Shortages Information Initiative web page.
Sponsors are required to report all shortages of reportable medicines. To date, the TGA has not been notified of any medicine shortage as a direct result of the coronavirus.
Customer engagement in COVID-19 times – Keep your people safe and maximise HCP reach digitally. Learn more about how we can assist your team – developed by industry for industry.
News & Trends - Pharmaceuticals
Australians face lengthy delays for PBS and Medicare claims: Has Labor brought Services Australia to its knees?
Wait times for health services through Services Australia have skyrocketed under the Labor Government, with Australians now enduring nearly three […]
MoreNews & Trends - Pharmaceuticals
Commission proposes major overhaul of obesity diagnosis
A global Commission, endorsed by 76 organisations – including Australian scientific societies and patient advocacy groups – has introduced a […]
MoreNews & Trends - MedTech & Diagnostics
Department of Health scraps Prescribed List reform measures amid stakeholder backlash
The Department of Health has declared “insufficient evidence” to justify legislating two proposed measures related to the Prescribed List (PL) […]
MoreLeadership & Management
Boehringer Ingelheim rolls out the red carpet for Hollywood
Boehringer Ingelheim has appointed a new General Manager for its Australia and New Zealand (ANZ) operations, with Ed Hollywood set […]
More